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Summary.-The Fractional Incorporation (FI) of [3H] thymidine ([3H]TdR) has been
examined in small lung tumours after cyclophosphamide (CY) treatment in vivo
and compared to the DNA specific activity (SA) at different times after treatment.
Fl was found to correlate with the incidence oflabelled cells after treatment, whereas
SA did not, due to the loss of DNA from drug-killed cells72 h after treatment. The
FT is independent of the precursor concentration in the tissue, and therefore may
give a better index of DNA synthesis in irregularly perfused tissues than SA.
Following either CY or 60Co radiation treatment, the time necessary for FT to
reach the pretreatment level is quite similar to the growth delay measured for the
corresponding treatment in the Lewis lung or B16 tumours. A relationship between
FT depression 45 h after treatment and growth delay has been established in the
Lewis lung tumour, which would allow the prediction of growth delay induced by
another agent to be made within 2 days of treatment.
ONE of the major problems associated
withthedevelopmentofanticancerregimes
or agents is that of quantification of
tumour response. Ideally, after treat-
ment, one would like to follow the change
in the number of clonogenic cells present
in the tumour, that is, the cells with the
capacitytorepopulate the tumour. How-
ever, at present, clonogenic assays are
available for very few tumours, and such
assays with primary human tumours
present formidable difficulties. Change
in tumour volume is one of the most
commonly used measures, but it will often
depend to an important extent on factors
other, than clonogenic cell killing, in
particular the rate of cell loss from the
treated tumour (Bagshawe, 1968;
Denekamp, 1972). Interpretation of
tumour volume change is particularly
difficult when there is a difference in the
rate of tumour growth before and after
treatment.
Biochemical methods used to assess
tumour response, most commonly based
on the rate of incorporation of [3H]
thymidine ([3H]TdR) or other labelled
precursors into DNA, have many attrac-
tionsifthedata canbeusefullyinterpreted.
The parameter most commonly used as a
measure of the rate of DNA synthesis has
beentheDNAspecificactivity(SA),thatis,
the amount of radioactivity incorporated
per unit DNA. This measure has certain
limitations when applied to studies in
tissues after treatment with cytotoxic or
other agents, since drug-induced changes
in precursor pool sizes or the activities of
polymerases or kinase enzymes may
influence the uptake of labelled precursor
into DNA in a manner that does not
reflect the changes in the numbers of cells
in the tissue which are engaged in DNA
synthesis. SA measurement has further
limitations when it is applied to tissues
having irregular perfusion or a low pro-
portion ofcycling cells, since the precursor
incorporation into DNA is proportional
to the amount of the precursor reaching
the tissue, and the SA is also dependentASSAYS OF TUMOUR GROWTH INBIBITION
on the total DNA content of the sample,
which includes contributions from non-
ccling cells (including those cells that
have ceased to cvele due to drug-induced
damage) as well as that from cveling cells.
Several clinical studies have shown a
correlation between a decrease in thy-
midine labelling index and a positive
clinical response, that is, a volume regres-
sion or a period ofstasis in tumour growth,
following chemotherapy (Skv-Peck, 1971:
Wolberg, 1971; WA-heeler, Dendy and
Dawson, 1974: Murphv et al., 1975). The
aim of this paper is to examine whether
data derived from the fractional incorpo-
ration technique described here can be
related to the tumour growth delay
following drug or radiation treatment.
MATERIALS AND METHODS
Pulmonarv tumours were produced from
single-cell suspensions prepared by tr,ypsiniz-
ing tumour fragments, and injecting 106
viable cells i.v. together mith 2 x 106
heavily irradiated cells (Hill and Stanley,
1975) suspended in Eagle's basal medium:
plastic microspheres were not used. Sub-
cutaneous and intramuscular Lewis lung
tumours or subcutaneous B16 mouse melano-
mas were produced in C57BL mice, by
injecting a cell suspension containing about
106 tumour cells in 0-05 ml medium intlo the
dorsal flank- or the gastroenemius muscle.
Cyclophosphamide (CY) solutions were
prepared shortly before i.p. injection. Both
treated and control aninmals were killed by
cervical dislocation under ether anaesthesia
1 h after injection of 5OiCi [3H]TdR (sp. act.
27 Ci/mmol: Radiochemical Centre, Amer-
sham). Pulmonary tumours (3-10 mg) were
carefullv dissected free from lung tissue.
weighed. and DNA was extracted bv a
modified Schmidt Thannhauser method
(Threlfall and Taylor. 1969). The acid-
soluble RNA and DNA fractions were
extracted in a total volume of 2 ml each.
whereas for subcutaneous and intramuscular
tumours the extraction volumes were 15 ml.
DNA was assaved bv u.v. absorption at
260 nm. corrected for protein contamination
(Lowry et al.. 1951) as described previouslv
(Munro and Fleck, 1968). Highlv polv-
merized calf thyvmus DNA (Sigma Chemical
Co.) was used forthepreparation ofstandards,
a solution containing 1 mg/ml giving an
optical density of 27 (Bevan, Holiday and
Johnson, 1955).
For radiation treatment of the intra-
muscular tumours the animals were anaesthe-
tized and irradiated with 6"Co y ravs at adose
rate of 50 rad/min. All areas of the body
other than the tumour-bearing leg, were
shielded with lead blocks during the treat-
ment.
For growth delay studies subcutaneous
tumours were treated at about 8 mm dia-
meter, and were measured using Vernier
calipers every 3 days. The tumour volume
was calculated from the measurement of 2
perpendicular diameters using the formula:
Vol -= x (mean diameter)3
The growth delay was taken as the increase
in time for the treated tumours to grow to 4
times their treatment volume compared to
the untreated controls.
Tumours used for autoradiographic
studies (ARG) were fixed in formol saline,
sectioned (6 ,um) and washed overnight with
water followed by HCI (5N) at room tempera-
ture to remove any labelled nucleotides
(Bianchi. Crathorn and Shooter, 1962). Sec-
tions were dipped in photographic emulsion
(Wlford K5) before being exposed for 2-4
weeks, and were stained with haematoxylin
and eosin. In experiments in which the
integrity oftumour cell nuclei was examined,
tissues were fixed in methanol-acetic acid
(3:1), stained with Giemsa and squashed on
a microscope slide.
The radioactivity due to 3H was measured
in an automatic liquid scintillation spectro-
meter (Intertechnique Ltd., Model SL40),
using an emulsion scintillant composed of 7
volumes of 0-6 (w/v) butyl-PBD in tloluene
and 3 volumes ofTergitol TP9 (Taylor, Tew
and Jones, 1976): results were corrected for
quenching.
The incorporation of [3H]TdR intoDNAis
expressed as DNA-specific activity (SA),
which is defined as the 3H content of the
extracted DNA (ct/min) divided by the DNA
content of the extract (mg), or as the frac-
tional incorporation (FI) of 3H-TdR into
DNA as defined by the expression:
3H in the DNA fraction (ct/mi.) x
Total 3H in the same tissue
sample (ct/min.)
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where total 3H is derived from the acid-
soluble DNA and RNA fractions of the
Schmidt Thannhauser extraction. In most
experiments less than 2% of the total tissue
radioactivity from [3H]TdR was extracted in
the RNA fraction. Fractional incorporation
results, after treatment, are expressed as
percentage of control. Where the distribution
of 3H was studied in subcutaneous tumours,
these were frozen and sectioned at 1-mm
intervals (cross-sections) and each cross-
section was subdivided. The radioactivity
of each 1-2 mm square was measured.
RESULTS
Following CY (300 mg/kg) the DNA
SA incidence of labelled cells per field and
thymidine Fl were depressed at 24 and
48h aftertreatment inpulmonary tumours,
but SA increased to greater than the
control level at 72 h (Fig. 1). The SA
data indicate an increase in the rate of
DNA synthesis or in the number of cells
in " S-phase " at this time, although the
number of cells per microscope field that
were labelled remained constant between
48 and 72 h, as did the grain count per cell.
There was an 80% fall in DNA/mg between
48 and 72 h in these pulmonary tumours,
which corresponds to a loss of nuclear
integrity, observed in tumour squashes at
this time after tumour treatment (Fig.
2).
For the assessment of the effects of
cytotoxic agents on cellproliferation, using
the rate of DNA synthesis as a marker, it
is desirable to have an index which is
independent of the total DNA content of
the tissue sample and the absolute level
of precursor uptake. The data in Table I
show that for a given tissue Fl is constant
over a greater than ten-fold range of
[3H]TdR dosage, whereas SA rises with
increasing dose (Cleaver, 1967). It appears
from Table I that tissues known to have a
high level of cell proliferation also have a
highFl of [3H]TdR, although quantitative
comparison between tissues is not possible
due to endogenous pool size variations
(Nygaard and Potter, 1959).
[3H]TdR concentration throughout a
2-g Lewis lung tumour was found to be
irregular 1 h after injection of [3H]TdR
(Fig. 3). The detailed distribution of
c
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Fia. 1.-The changes in DNA-specific activity (0), the number of labelled cells per field (A) and the
fractional incorporation of [3H]TdR (ED) in pulmonary Lewis lung colonies after cyclophosphamide
(CY) (300 mg/kg) treatment.
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FIG. 2.-Following CY (300 mg/kg), tumour cell nuclei appeared intact for up to 48 h after treatment.
Giemsa-stained cells showed considerable nuclear fragmentation after 72 h. (a) Nuclei from
untreated tumour cells; (b) tumour cell nuclei 48 h after CY; (c) Nuclei 72 h after CY.
radioactivity in cross-section D (ct/min/ The relaiownhip bween fractional incor-
mg) is shown, and higher concentrations of poration and growth delay
radioactivity, were observed in the outer
2-3 mm in most sections, compared to the The El of [3H]TdR into DNA of
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TABLE I.-The DNA Specific Activity (SA as ct/min/my D1NA x 103) and the Fractional
Incorporation (FI) in Several Tissues, Following the Administration of Increasing
Doses of [3H]TdR to Non-tumour-bearing Animals
Dose*
12-5 50 100 200
Tissue SA Fl SA Fl SA Fl SA Fl
GITt 140415 81-7±0-2 480±20 80-6475 881±0-5 79-8±0-7 2125±95 78 5±1 6
epithelium
Heart 3 5±0-2 4 11±02 15-3±1-6 5-4±0-8 32-3±3 5-9+0-2 551-1-42 4-1±0-5
Liver 7-6±0-3 4-3±0-8 28±4-7 5 010-3 75 1±4 6 2±1 1044-13 4-5±0-5
ILung 4 1±0 2 14-6±1 16-3±1-2 17-9±1 32-5, 2 17-6±0-7 72-5±3-1 16-2±1
Kidney 2-89±0-07 3 9+0 3 10-2±0 9 5-1±0-4 22-6±0-5 4-5+0-1 372--4 4 50 06
Spleen 18-8±1-8 67-1±5 81-7±8 72-3±1-4 189±42 76-8±3 297±30 68-5±3
* Dose is iCXi/25 g body weight. Results are given as MIean ± s.e.
t Gastrointestinal.
ct/min/mg xlO
Tumour sectiotied cross-section
at 1 mm intervals.
_~~~~~~~~~~~~~~~~~....,'' ..
A B C D E F G H J K
TUMOUR CROSS-SECTION
FI. 3. The top) figure show,s the (listribultionl of 3H in cross-sectionl D, I h af'ter [3H]TdlR admlini-
stration to the host (ct/mm/lmg). The mean concenItrntion of radlioactivity in the oultsidec 2
s;ections for each 1 mm cross-sqection (,sections A-K) of this 2-g tumoulr have been compared to the
concentration of" inside " areas wvithin each cross-section (those pecies greater than 2 piececs from
the outer edge of the tumour inside the (double line in section D above). The "oultside, areas
(black) generally ,showed the higher 3H-1/mg. (Mean 2 s.e.)
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FIG. 4.-The FI of 3H-TdR in sc. Lewis lung carcinomas was measured for up to 300 h following
the administration ofvarious dose levels ofCY to groups ofaninals. Data areplotted as a fraction
of the untreated tumour Fl (Mean 4- s.e.).
TABLE II.-A Comparim between the Mean Growth Delay (i 8.e.) and the Fractional
Incorporation (FI) Recoery Times for Corresponding Treatments in 2 Transplantable
Rodent Tumours
Tumour
Lewis lung carcinoma
Subcutaneous
]Intramuscular
B16 melanoma
Subcutaneous
Treatment/dose (mg/kg or rad)
Cyclophosphamide 300
200
100
50
'"Co radiation 3000
2000
1000
Cyclophosphamide 300
200
100
50
25
Fl recovery time (h)
325
230
112
50
180
110
50
520
320
176
100
50
Growth delay (h)
350±50
230±36
84412
Not significant
166+27
80± 8
Not significant
550±20
330±20
150± 12
intervals for up to 300 h after treatment
with various doses ofCY. The depression
and recovery of El appears to be dose-
related (Fig. 4), although Fl was only
depressed by 80% at a dose level that
leaves a clonogenic cell fraction of around
1 x 10-6 (Steel and Adams, 1975). There
is a good agreement between the Fl
recovery time, (the time for El to reach
the pretreatment level), and the tumour
volume growth delayforthe corresponding
dose of CY (Table H).
The effect of local 60Co irradiation of
intramuscular Lewis lung tumours is
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FIG. 5.-The FI of [3H]TdR of i.m. Lewis lung tumours at various times following localized 6tCo radiation.
No significant overshoot in Fl was observed upon recovery. (Mean ± s.e.).
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FIG. 6.-The recovery times for FI of tumours growing in different sites within the host following various treatments, plotted against the reduction in FI at 45 h after treatment, (100 -Fl at 45 h). (Mean i s.e.).
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TABLE III. ThePredicted Recovery time for Fl (fromFig. 4)
is Quite Close to the Observed Recovery Time in the Lewis
Lung Tumours
Predicte(I
recovery
Dose mg/kg Fl at 45 h 100 FI time (h)
100 56 44 125
150 39 60 210
200 36 64 260
250 31 69 300
300 27 73 350
shown in Fig. 5, where the general pattern
of change in FL is similar to that measured
after CY treatment. The recovery time
for FL and measured growth delay are
similar (Table LI).
The recovery time for Fl serves as an
alternative to the measurement of growth
delay, but since the pattern ofFl response
in the Lewis lung tumour was similar
following CY or radiation, we attempted
to predict the FL recovery time from the
depression of Fl at a single time after
treatment. Fractionalincorporation values
45 h after treatment in all sites of tumour
growth after either CY or 60Co radiation
showed a clear relationship between the
Fl depression and its recovery time
(Fig. 6). It was of interest to attempt to
establish FL recovery time (and hence
growth delay) from only a single time.
Groups of animals were given either CY
or saline (control) and FL was measured
45 h later, and expressed as a fraction of
the control level. The recovery time
corresponding to the Fl depression at 45 h
was read from Fig. 6, and the predicted
recovery time was found to be similar to
the growth delay measured for the
corresponding dose level (Table LLL).
Limited studies using subcutaneous
B16 tumours have shown that FL is
depressed quite considerably and recovers
in a dose-dependent fashion after CY
administration (Fig. 7).
DISCUSSION
Seventy-two hours after CY admini-
stration, the DNA SA in small Lewis lung
tumours growing in the lungs shows a
considerable increase to above the pre-
treatment level, without a corresponding
rise in the incidence of labelled cells, or an
increase in grain density at this time.
The number of labelled cells per field, and
the grain density per labelled cell appear
to remain constant between 48 and 72 h
after treatment, although considerably
depressed from the control level. The
increase in SA does not therefore appear to
represent an increased rate of DNA
synthesis or level of new cell production at
this time after treatment. Following CY
or 60Co radiation, damaged cells may
continue to cycle before dying (Peel and
Cowan, 1972). However, the increase in
SA may be explained by the lysis of nuclei
3 days after treatment, shown by the
reduced DNA/mg at this time and by the
disruption of nuclei observed in cell
squashes. If the incorporation of [3H]
TdR into DNA remains constant between
48 and 72 h (shown by autoradiographs),
the loss of DNA from drug-killed cells will
reduce the denominator in the SA cal-
culation. FL changes measured at various
times after CY treatment appear to
correlate with the number of labelled cells
per field in the pulmonary tumours
studied. Where irregular permeation of
the radio-labelled precursor occurs, as in
subcutaneous Lewis lung tumours, the FL
may serve as a better index of new cell
production than SA, as the latter may
reflect the availability of the precursor
rather than the level of DNA synthesis.
The recovery times for [3HI]TdR in the
Lewis lung and the B16 tumours are quite
Actual
recovery
time (h)
110
180
230
290
330
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similar to the growth delay caused by the
corresponding treatment. It is probably
fortuitous that the two measurements are
so similar, for where the tumour regrows
at a different rate from the control (as
does the B16 tumour following CY) the
growth delay is continually changing as
growth proceeds. For example, where the
post-treatment doubling time is slower
than before treatment, the growth delay
will continue to increase with time after
treatment. By measuring growth delay
at a time when the treated tumour has
reached 4 times its treatment volume, a
sufficient period has been allowed for most
of the drug-induced debris to be removed.
However, where little cell killing has been
achieved, for example less than one order
of cell killing, then it is probable that
regrowth will occur before the debris has
been removed. Consequently the growth
delay may be less than that expected for
the level of cell killing due to repopulating
cells " building " on to debris.
It would appear that the recovery
curve for [3H]TdR Fl in these tumours is a
composite function determined by the rate
of repopulation of the tumour by clono-
genic cells, and the rate at which damaged
cells cease to cycle.
In these 2 rodent tumours it would
appear that depression of Fl within a few
days of treatment may be related to the
tumour growth delay. Where such a
relationship has been established for the
tumour line, it may be possible to predict
the growth delay corresponding to Fl
depression produced by another agent.
Such an assay would permit the rapid
assessment of agents used singly or in
combination in tumours such as human
tumour xenografts which are not suitable
for in vitro procedures.
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